Transcriptomic analyses revealed that cancer-associated SF3B1 mutations are generally associated with the usage of alternative 3’ (a3′ss) ~10–30 nucleotides upstream of the canonical 3’ss. This evidence concerns the gene SF3B1 and cancer.